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Clinical evaluation of the direct and indirect detection of the causal agent of Lyme 
disease in the horse 
 
The clinical diagnosis of Lyme disease (LD) in horses is often established by detection of 
Borrelia (B.) burgdorferi sensu lato (s.l.) antibodies in conjunction with clinical symptoms as 
specified in literature. Because of the lacking standardization of the tests it turned out that the 
detection of Borrelia in the specimens was very difficult.The aim of the study was to evaluate 
the common practice of serological testing for the establishment of the diagnosis LD in 
horses. 
 
337 patients referred to the Clinic for Horses, Surgery and Radiology of the Freie Universität 
Berlin were examined clinically for a period of ten month and the collected samples were 
tested further in the laboratory of the BgVV1 Berlin. The probands were classified in group A 
(horses independent of clinical symptoms, n=195) and group B (horses with clinical 
symptoms, n=142) after a full clinical examination. 
In the study serum samples of horses (n=337) were tested using two commercial ELISA 
testkits (A and B), an ELISA (C) and IFT homemade at the BgVV for B. burgdorferi s.l. 
antibodies (immunglobulin G). In addition, specimens of skin, liquor, synovial fluid and blood 
of horses with clinical symptoms were analysed by PCR and cultivation (n=76). 
In order to determine the sensitivity of the serological assays, both positive controls of the 
commercial ELISA testkits (A and B), 5  highly positive sera of each  ELISA (A, B and C) and 
3 sera tested negative in all of them were examined with Western blot (ALOMED2, n=20). 
The positive control of the ELISA C consisted of a sample that was high positive in all 
serological tests. 
In a further study, 15 liquor samples were tested for B. burgdorferi s.l. antibodies 
(immunglobulin A, M and G) and the corresponding serum samples (n=15) for immunglobulin 
M and G using another ELISA (LGL3). In our investigations we examined Lyme disease in 
horses using direct methods for detection of B. burgdorferi s.l.: culture and Polymerase 
Chain Reaction (PCR). For the culture of B. burgdorferi skin (n=16), liquor (n=15) and 
synovial fluid (n=26) were inoculated into BSK- and MKP-medium native and with different 
inhibitoring substances.  
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Cultures were incubated for 3 months at 33°C, subcultivated and examinated weekly by 
dark-field microscopy. Skin (n=16), liquor (n=15), synovial fluid (n=26) and blood (n=19) were 
tested for the presence of B. burgdorferi s.l. specific DNA by OspA-specific nested PCR.  
In order to determine the specivity of the nested PCR the positive PCR-results were 
examined with Realtime PCR (ALOMED). 
 
The results of the serologic testing revealed a high discrepancy within the tested probands. 
Following proportions of positive antibody titers were found (n=337): ELISA A: 61,1%, 
B: 9,8%, C: 3,3%. In the IFT 33,2% of samples were positive (cut off 1:128). Compatibility of 
results of serological tests existed in 22,0% of samples (74/337), only 1,8 % of samples were 
positive in all tests (6/337). There was no significant difference in serological results between 
horses with (group B) and without (group A) clinical symptoms of LD. A correlation between 
symptoms and seropositivity of serum samples could not be proved. 
In the Western blot, positive (n=15) and negative in all ELISA  (n=3) sera except the positive 
controls of the commercial ELISA testkits (A and B) were confirmed. 
The LGL-ELISA detected incidences of seropositive samples (depending on dilution of 
serum) as follows: 53,3% (1:50), 26,7% (1:200) and 6,7% (1:400). These results are in 
correspondence with ELISA A. 
The cultivation of B. burgdorferi was negative in all cases (n=57). In one of them we could 
find immobile spirochete-like forms. They are supposed to be “giant whips”, flagellae of the 
contaminant flora, which are not involved in the development of Lyme disease.  
In the OspA-specific nested PCR 3 skin (3/16), 2 liquor (2/15), 6 synovial fluid (6/26) and 
1 blood (1/19) samples were positive for B. burgdorferi s.l.-DNA. In the Realtime PCR none 
of these 12 positive samples were positive for B. burgdorferi s.l.-DNA (0/12). A correlation 
between seropositivity of serum samples and the presence of specific DNA could not be 
proven. 
 
These contradictory results revealed the necessity for evaluation of current direct and 
serological laboratory testing for B. burgdorferi s.l. Without standardised methods 
(concerning antigencoating, serumdilution, positive control) for the serodiagnostical tests the  
demands regarding specifity and sensitivity are not met. Reliable laboratory tools are a 
prerequisite under which a characteristic titerdynamic in conjunction with clinical signs can 
leed to the presumptive diagnosis LD. Due to the lack of standardization of  PCR and the 
complex demands on cultivation direct detection of B. burgdorferi s.l. is not a suitable method 
for routine diagnostic at the moment. 
 
